Novo Nordisk to lower prices of several insulin products
Novo Nordisk NOVO.B, +0.15% NVO, -0.53% said that it is lowering the prices of several insulin products by up to 75% starting in 2024. The company’s U.S.-listed shares were up about 1.0% in premarket trading on Tuesday.
The Danish drugmaker said it will reduce the price of NovoLog and NovoLog Mix 70/30 by 75% and Novolin and Levemir by 65%. The move follows Eli Lilly’s announcement that it also plans to lower the prices of some of its insulin products. Novo’s stock has gained 3.8% so far this year, while the broader S&P 500 SPX, -0.15% is up 0.8%.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WSJ News Exclusive | Novo Nordisk to Slash Insulin Prices by Up to 75%Breaking: Novo Nordisk, a large insulin maker, plans to cut the prices of its widely used products up to 75% to make them more affordable for patients. This follows a similar move by Eli Lilly.
Read more »
Lilly Insulin Value Program | Lilly Insulin AffordabilityLilly is committed to helping people with diabetes get the medicine they need, regardless of whether you have commercial insurance or no insurance. Learn more about how Lilly may be able to help with potential cost saving solutions.
Read more »
Disability rights leader, Judy Heumann, dies at 75Judy Heumann, the brave woman who was denied a teaching position because she was in a wheelchair and turned the rejection into a lifetime of disability activism that changed the world, has died at 75. Sunday TODAY’s Willie Geist remembers a life well-lived.
Read more »
SVB collapse: Markets start pricing in Fed rate cuts of 75 basis pointsMarkets have started pricing in Fed rate cuts of 75 basis points by the year's end as SVB's collapse creates panic about other banks
Read more »